THY1 and nephritis: Kunter et al. have previously demonstrated that MSCs also reduced mesangiolysis in anti-Thy1-induced nephritis when injected into the renal artery, but not when infused i.v. In fact, treatment with MSCs via renal artery resulted in the recovery of serum creatinine to baseline levels with a significant reduction in proteinuria [16].